40. Takayasu arteritis
22 clinical trials,   46 drugs   (DrugBank: 20 drugs),   22 drug target genes,   111 drug target pathways

Searched query = "Takayasu arteritis", "Aortitis syndrome", "Pulseless disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04299971
(ClinicalTrials.gov)
March 1, 20205/3/2020Efficiency of Methotrexate and Tofacitinib in Mild and Moderate PatientsRandomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort.Takayasu Arteritis;Methotrexate;Inhibition;TreatmentDrug: Methotrexate Tablets;Drug: Tofacitinib tabletShanghai Zhongshan HospitalNULLRecruiting14 Years100 YearsAll130Phase 4China
2NCT03096275
(ClinicalTrials.gov)
March 16, 201713/3/2017Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's ArteritisComparison of the Efficacy of Mycophenolate Mofetil Combined With Methotrexate and Cyclophosphamide for the Treatment of Takayasu's ArteritisTakayasu ArteritisDrug: MMF;Drug: CYC;Drug: Glucocorticoids;Drug: MTX;Drug: AZAChinese SLE Treatment And Research GroupPeking Union Medical College HospitalRecruiting18 YearsN/AAll150Phase 3China